Related Experiment Video
Updated: Jun 5, 2026
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Dual gene targeted multimeric siRNA for combinatorial gene silencing.
Soo Hyeon Lee1, Hyejung Mok, Sungduk Jo
1Department of Biological Sciences, The Graduate School of Nanoscience and Technology, Korea Advanced Institute of Science and Technology, Daejeon 305-701, Republic of Korea.
Biomaterials
|December 25, 2010
Summary
Multimerized small interfering RNA (siRNA) conjugates offer superior gene silencing compared to simple mixtures. Cleavable dual-gene targeted siRNA conjugates effectively inhibit multiple genes, enhancing therapeutic potential for diseases like cancer.
Area of Science:
- Biochemistry
- Molecular Biology
- Gene Therapy
Background:
- Simultaneous silencing of multiple genes is a promising strategy for treating complex diseases like cancer.
- Current methods often involve physical mixtures of small interfering RNAs (siRNA), which may lack optimal efficiency.
Purpose of the Study:
- To develop and evaluate novel multimerized siRNA conjugates for efficient simultaneous silencing of multiple target genes.
- To compare the efficacy of cleavable versus non-cleavable dual-gene targeted multimeric siRNA (DGT multi-siRNA) conjugates.
Main Methods:
- Chemically crosslinking two distinct siRNA sequences into a single backbone using cleavable (disulfide) and non-cleavable linkages.
- Preparing dual gene targeted multimeric siRNA conjugates (DGT multi-siRNA) and single gene targeted multimeric siRNA (SGT multi-siRNA).
- Assessing gene silencing efficiency at mRNA and protein levels, and evaluating immune response and apoptotic effects.
Main Results:
- Cleavable DGT multi-siRNA demonstrated significantly higher gene silencing efficiency compared to non-cleavable DGT multi-siRNA, physical siRNA mixtures, and SGT multi-siRNA.
- The DGT multi-siRNA approach showed minimal immune response.
- DGT multi-siRNAs targeting therapeutic genes (anti-survivin and anti-bcl-2) induced a greatly enhanced apoptotic effect.
Conclusions:
- Cleavable multimeric siRNA conjugates provide a superior platform for concurrent suppression of multiple therapeutic target genes.
- This approach holds potential for improved therapeutic efficacy in treating diseases driven by multiple gene targets.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:30Small interfering RNAs (siRNA)
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...